Last reviewed · How we verify
Propranolol twice a day
At a glance
| Generic name | Propranolol twice a day |
|---|---|
| Sponsor | The University of Texas Health Science Center, Houston |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Assessing the Impact of Dosage Frequency of Propranolol on Sleep Patterns in Patients With Infantile Hemangiomas (PHASE4)
- Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study (PHASE4)
- ACT Therapy for HF Migraine (NA)
- CLOZAPINE Response in Biotype-1 (PHASE4)
- A Study of Propranolol to Treat Kaposi Sarcoma (PHASE2)
- Carvedilol vs. Propranolol for Preventing Rebleeding After Endoscopic Treatment of Cirrhotic Varices (PHASE4)
- Propranolol With Tislelizumab Plus GC in Neoadjuvant Bladder UC (PHASE1)
- Effectivity and Safety of GB20 Acupoint Pharmacopuncture With Lidocaine 2% on Migraine Patients (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: